Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

Clinical trial NCT00680446 · COMPLETED

Trial details

NCT number: NCT00680446
Sponsor: CSL Limited
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Immune Deficiency

Start date: 2008-04-01
Primary completion: 2013-05-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.